Cited by 1,093Cancer Risks and FactorsEstrogen and related hormone effectsMenopause: Health Impacts and Treatments

Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women

Endogenous Hormones Breast Cancer Collaborative Group·2003·JNCI Journal of the National Cancer Institute

Abstract

BACKGROUND: Obesity is associated with increased breast cancer risk among postmenopausal women. We examined whether this association could be explained by the relationship of body mass index (BMI) with serum sex hormone concentrations. METHODS: We analyzed individual data from eight prospective studies of postmenopausal women. Data on BMI and prediagnostic estradiol levels were available for 624 case subjects and 1669 control subjects; data on the other sex hormones were available for fewer subjects. The relative risks (RRs) with 95% confidence intervals (CIs) of breast cancer associated with increasing BMI were estimated by conditional logistic regression on case-control sets, matched within each study for age and recruitment date, and adjusted for parity. All statistical tests were two-sided. RESULTS: Breast cancer risk increased with increasing BMI (P(trend) =.002), and this increase in RR was substantially reduced by adjustment for serum estrogen concentrations. Adjusting for free estradiol reduced the RR for breast cancer associated with a 5 kg/m2 increase in BMI from 1.19 (95% CI = 1.05 to 1.34) to 1.02 (95% CI = 0.89 to 1.17). The increased risk was also substantially reduced after adjusting for other estrogens (total estradiol, non-sex hormone-binding globulin-bound estradiol, estrone, and estrone sulfate), and moderately reduced after adjusting for sex hormone-binding globulin, whereas adjustment for the androgens (androstenedione, dehydroepiandrosterone, dehydroepiandrosterone sulfate, and testosterone) had little effect on the excess risk. CONCLUSION: The results are compatible with the hypothesis that the increase in breast cancer risk with increasing BMI among postmenopausal women is largely the result of the associated increase in estrogens, particularly bioavailable estradiol.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/jnci/djg022

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Obesity is associated with higher circulating and white-adipose-tissue-derived E1 levels.

    “obesity is associated with higher circulating and WAT-derived E1 levels (64, 135–138)”

    From Metabolic impact of endogenously produced estrogens by adipose tissue in females and males across the lifespan (2025) · cites this paper as [138]

    The Results report that serum estrone was significantly higher with increasing BMI in postmenopausal women, supporting the circulating E1 portion. The paper discusses estrogen production in adipose tissue, but does not measure or specifically report higher white-adipose-tissue-derived estrone levels. (LLM, conf=0.86)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 11

  1. International Agency for Research on Cancer (IARC). Weight and weight control: breast cancer. In: IARC Handbooks of Cancer Prevention. Weight control and physical activity. Lyon (France): IARC Press; 2002. p. 95-112.
  2. Judd HL, Shamonki IM, Frumar AM, Lagasse LD. Origin of serum estra- diol in postmenopausal women. Obstet Gynecol 1982;59:680-6.
  3. Siiteri PK, Hammond GL, Nisker JA. Increased availability of serum estrogens in breast cancer: a new hypothesis. In: Pike MC, Siiteri PK, Welsch CW, editors. Banbury Report 8. Hormones and breast cancer. Cold Spring Harbor (NY): Cold Spring Harbor Laboratory Press; 1981. p. 87-106.
  4. Dorgan JF, Longcope C, Stephenson HE, Falk RT, Miller R, Franz C, et al. Relation of prediagnostic serum estrogen and androgen levels to breast cancer risk. Cancer Epidemiol Biomarkers Prev 1996;5:533-9.
  5. Dorgan JF, Stanczyk FZ, Longcope C, Stephenson HE, Chang L, Miller R, et al. Relationship of serum dehydroepiandrosterone (DHEA), DHEA sulfate, and 5-androstene-3 beta, 17 beta-diol to risk of breast cancer in postmenopausal women. Cancer Epidemiol Biomarkers Prev 1997;6: 177-81.
  6. Barrett-Connor E, Friedlander NJ, Khaw KT. Dehydroepiandrosterone sul- fate and breast cancer risk. Cancer Res 1990;50:6571-4.
  7. Kabuto M, Akiba S, Stevens RG, Neriishi K, Land CE. A prospective study of estradiol and breast cancer in Japanese women. Cancer Epidemiol Bio- markers Prev 2000;9:575-9.
  8. Gordon GB, Bush TL, Helzlsouer KJ, Miller SR, Comstock GW. Rela- tionship of serum levels of dehydroepiandrosterone and dehydroepiandros- terone sulfate to the risk of developing postmenopausal breast cancer. Can- cer Res 1990;50:3859-62.
  9. Helzlsouer KJ, Alberg AJ, Bush TL, Longcope C, Gordon GB, Comstock GW. A prospective study of endogenous hormones and breast cancer. Cancer Detect Prev 1994;18:79-85.
  10. Kaaks R, Lukanova A, Kurzer MS. Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review. Cancer Epidemiol Biomarkers Prev 2002;11:1531-43.
  11. Muti P, Quattrin T, Grant BJ, Krogh V, Micheli A, Schunemann HJ, et al. Fasting glucose is a risk factor for breast cancer: a prospective study. Cancer Epidemiol Biomarkers Prev 2002;11:1361-8.

Cited by

Sorted by citations

Authors
Endogenous Hormones Breast Cancer Collaborative Group
Affiliations
University of Oxford (GB)
Corresponding author
Endogenous Hormones Breast Cancer Collaborative Group
Venue
JNCI Journal of the National Cancer Institute
Published
2003-08-19
Volume
95
Issue
16
Pages
1218-1226
ISSN
  • 0027-8874 (ISSN-L)
  • 1460-2105
OpenAlex
W1551632868
Cited by
1,093
References
28
Citations by year
2026: 15 · 2025: 19 · 2024: 26 · 2023: 27 · 2022: 45 · 2021: 41 · 2020: 48 · 2019: 42 · 2018: 39 · 2017: 56 · 2016: 50 · 2015: 66 · 2014: 63 · 2013: 68 · 2012: 54
FWCI
5.35
Type
journal article
Language
en
Open access
closed
Locations
  • JNCI Journal of the National Cancer Institute (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Brigham and Women's Hospital
  • University of Southern California
  • University of Missouri
  • University of Connecticut
  • Johns Hopkins University
  • University of Pittsburgh
  • Kagoshima University
  • York University
  • University of Oxford
  • School of Medicine, New York University
  • University of California, San Francisco
  • University at Buffalo
  • National Cancer Institute
  • Division of Cancer Epidemiology and Genetics, National Cancer Institute
Topics
  • Health Sciences › Medicine › Oncology › Cancer Risks and Factors
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Estrogen and related hormone effects
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
Keywords
breast cancer risk, body mass index, obesity, postmenopausal women, serum sex hormones, estradiol, bioavailable estradiol, estrogen, sex hormone-binding globulin, androgens, estrone, estrone sulfate
MeSH terms
Aged, Breast Neoplasms, Estradiol, Female, Humans, Middle Aged, Prospective Studies, Risk Factors, Gonadal Steroid Hormones, Body Mass Index, Logistic Models, Case-Control Studies, Postmenopause, Risk Assessment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review